Aldosterone antagonists (spironolactone ... with recent or current New York Heart Association functional class IV symptoms, preserved renal function and a normal potassium concentration.
Purpose: The clinical benefits, adverse effects, pharmacokinetics, and recommendations for the appropriate use of the aldosterone antagonists spironolactone and eplerenone in patients with heart ...
The current ACC/AHA guidelines for the management of HF recommend aldosterone antagonists (spironolactone or eplerenone) in patients with HFrEF and NYHA Class II to IV symptoms to reduce morbidity ...
Aldosterone Receptor Blockers ... on survival in severely symptomatic (New York Heart Association class IV) heart failure patients taking an ACE inhibitor, loop diuretic, and digoxin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback